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ABSTRACT
Acne vulgaris is a very common skin disease. It affects almost everybody at a certain age. Many studies
tried to understand the role of smoking in the pathogenesis of acne. Unfortunately, contradictory results have
been reported. The goal of this study is to conduct a case-control study investigating the association between
smoking and acne vulgaris. A case-control study was performed during October 2017. A questionnaire was
administered to be filled carefully. Our cases were outpatients who have visited dermatologists for acne.
Controls were students randomly chosen from Al-Quds University. Acne stratification based on mild,
moderate, severe was done according to the number and type of acne. Crude and adjusted Odds Ratios (OR)
with the 95%confidence interval (95%CI) were used. Crude and adjusted OR between acne and smoking
showed no association except for people above the age of 20 years old. Crude OR was at 0.782 with 95%
IC= (0.451-1.354); adjusted OR for sex and age was at 1.237 with 95% CI (0.654-2.319) and 1.453 with 95%
CI (0.770-2.740), respectively. Adjusted OR for people ≥20 years of age was significant at 1.779 with 95%
CI (1.006-3.148). There was no association between acne and smoking based on the results we obtained.
Nevertheless, smokers who were ≥20 years of age had a slight increase in risk compared to smokers who
were <20 years of age, with a significant adjusted OR ratio of 1.779 95% CI (1.006-3.148).
Keywords: smoking, acne vulgaris
INTRODUCTION
Acne is a very common skin disease. It is
mostly encountered during adolescence, and
sometimes continues into adulthood (1). It occurs
when the hair follicles are clogged with dead skin
cells and oil. It presents with blackheads,
whiteheads, pimples, and possible scarring. In
adolescence, it is usually caused by an increase in
testosterone level. Although Adolescence is the
period when most people have acne, recent
epidemiological studies have shown that acne
affects a significant percentage (12–14%) of
women between 25 and 50 years of age (2). Postpubertal acne is described as an inflammatory
mild-moderate form, whose cause is still
unknown and whose incidence is increasing (3).
Smoking is a worldwide social and health
problem. Beyond its known links to cancer, lung
and heart disease, it is associated with premature
skin ageing, delayed wound healing, and a
number of skin diseases. Smoking provokes
important alterations on the skin microcirculation,
keratinocytes and collagen and elastin synthesis.
Nicotine also induces vasoconstriction of vessels
and inhibits inflammation through effects on
nervous and immune system (4).
Recent studies on the correlation between
smoking and acne have reported conflicting
results. Some have shown no correlation at all (1);
some have concluded that smoking aggravates

acne; and on the other hand, some concluded that
smoking may have an anti-inflammatory effect
and improve the acne condition (2). Interestingly,
Researchers at the San Gallicano Dermatological
Institute in Rome reported that clinical evidence
and experimental data showed a correlation
between smoking habit and acne vulgaris only
after a specific age after puberty(6).
Now, a true association between acne and
smoking has not yet been confirmed. Due to the
conflicting previous studies, the goal of this study
is to investigate the association between smoking
and acne vulgaris.
METHODS
Study Design
This was a case-control study. This study is
being reported in adherence to the STROBE
checklist (7). Cases were outpatients who have
visited dermatologists for acne and still have the
disease. Controls were randomly chosen students
from Al-Quds University. The questionnaires
were distributed and filled in a period between
October 1, 2017 to the October 20, 2017.
Participants have given their voluntary, informed,
and oral consent of the study before filling the
questionnaire.
Study participants
The eligibility criteria were as follows:
participants’ age was set between 14 and 50 years
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old, no contraceptive use in women, no history of
diabetes or cardiovascular diseases, and no
history of anabolic steroids intake. However,
individuals with previous medication for acne
vulgaris were accepted in the sample.
The sample was chosen randomly; and we did
not discriminate based on gender or age. Controls
were chosen at the same time among healthy
population and from the same community.
Study tools
Currently, there is no accepted universal acne
grading system. In our study, we stratified our
sample according to classification of Lehmann et
al (8) (Table 1). This criterion classifies patients
into three groups (mild, moderate and severe)
based on the type and number of lesions. A
patient with less than 30 lesions is considered a
mild case. A patient with 30 to 125 lesions is
considered moderate case. A patient with more
than 125 lesions is considered a severe case,
given the fact that the type of the lesion weighted
differently as explained in (Table 1). We selected
this grading system because it can be easily
applied by the physician who conducted the study
and did not require any further laboratory
investigations.
Table (1): Basis for classification of acne
vulgaris cases used in this study

Comedones

Mild

Moderate

Severe

<20

20 - 100

>100

< 15

15 - 50

Papules / Pustules

> 50

Nodules / Cysts
Total

>5
< 30

30 - 125

> 125

This classification was adopted from Lehmann et al

The case to control ratio was almost 1:1.23.
The estimate of smoking prevalence among our
sample was 47.1%. In this study, a total of 206
patient records were collected (97 patients with
acne vulgaris and 109 healthy controls).

comprised essentially of socio-demographic data
and questions on smoking habits, prior treatment
of acne, and other factors that contribute to acne
pathogenesis.
Statistical analysis
Differences between cases and controls were
analyzed using parametric and non-parametric
tests. Statistical analysis included the range and
median of the sample’s age and gender, and
percentages stratifying the severity of acne. In
addition, a binary logistic regression was
conducted which indicated the contribution of a
particular predictor when other predictors are
controlled. The odds ratio was estimated through
the calculation of regression with a confidence
interval of 95%.
The statistical analysis was conducted using
the statistical package SPSS for Windows (release
20). The statistical significance was set at p <
0.05.
RESULTS
In this study, there were a total of 206 records
(97 patients with acne vulgaris and another 109
healthy individuals). Of the 97 patients with acne
vulgaris, 56 were male and 41 were female. The
median age of female smokers was 22 years
(range 18-40 years) and the median age of male
smokers was 20 years (range 15-42 years).The
median age of nonsmoker participants was 19
years for females and 19 years for males. Smoker
males were 83 participants, of those 34 (40%) had
acne. On the other hand, the smoker females were
15 participants, of those nine (60%) had acne.
Non-smoker males were 47 (22 cases and 25
controls) and nonsmoker females were 61 (32
cases and 29 controls).
From a clinical point of view, the severity of
the cases was as follows: out of 97 cases,
11(11.3%) had a severe grade of acne vulgaris,
48(49.5%) had a moderate grade of acne vulgaris,
and 38(39.2%) had a mild grade of acne vulgaris
as shown in Figure 1. Similarly, out of 43
smoker-cases, 5(11%) had a severe grade of acne,
20(46%) had a moderate grade of acne vulgaris,
and 18(41%) had a mild grade acne as shown in
Figure 2.

A questionnaire was administered on each
participant in order to assess the correlation
between smoking and acne. The questionnaire
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Severity of Acne in our 97 cases

severe grade acne

moderate grade acne

mild grade acne

Figure(1): Severity distribution of acne cases (n = 97) who participated in the study

Severity of acne in our 43 smoker-cases

severe grade acne

moderate grade acne

mild grade acne

Figure(2): Severity distribution of acne in those who were smokers (n = 43)
The crude OR for the association between
acne vulgaris and smoking was 0.782 with a 95%
CI (0.451-1.354), while the adjusted OR for sex
and age was at 1.237 with a 95% CI (0.659-

2.319) and 1.453 with a 95% CI (0.770-2.740),
respectively. Adjusted OR for participants who
were ≥20 years of age was significant at 1.779
with a 95% CI (1.006-3.148) as shown in Table 2.
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Table (2): Association between acne and sociodemographic variables of the study participants
Variables

Case n (%)

Control n (%)

OR(95% CI)

Adjusted OR (95% CI)

Current smokers

43(44.3)

55(50.4)

0.782 (0.451- 1.354)

1.237 (0.659-2.319)

Non–smoker

54(55.6)

54(49.5)

Female

41(42.2)

35(32.1)

0.646 (0.366-1.141)

1.453 (0.770-2.740)

Male

56(57.7)

74(67.8)

≥ 20years

56(57.7)

49.(44.9)

0.598 (0.344-1.038)

1.779 (1.006-3.148)

< 20 years

41(42.2)

60(55)

DISCUSSION
In this study, there was no significant
difference in the prevalence of acne and the sociodemographic variables, nevertheless, smokers
who are more than 20 years old had a significant
increased risk of developing acne.
Acne is a chronic, inflammatory skin
condition that causes spots and pimples,
especially on the face, shoulders, back, neck,
chest, and upper arms. It is one of the most
common skin diseases as it affects almost 85
percent of adolescents.
Skin and hair are exposed to various
environmental noxious agents, including tobacco
smoke. Smoking is associated with skin ageing,
and poor wound healing (9). A general
observation that smokers tend to be more severely
affected than non-smokers by the majority of
inflammatory skin diseases particularly psoriasis,
hidradenitis suppurativa, cutaneous lupus
erythematosus and acne have been reported.
In this study, we were interested in the
association between and smoking and acne
vulgaris since previous studies showed
contradictory results. The choice of our study
design (case-control study) is authoritative, which
studies the present association between acne
vulgaris and smoking, according to an association
between the exposure and disease in the past.
Most of the studies regarding this association
were conducted in Western communities. Some
articles showed a positive association (6), others
instead showed a negative association between
smoking and acne, assuming that smoking exerts
an anti-inflammatory role in pathogenesis of the
disease (5). This study aimed to study specifically

the Palestinian community and their response to
smoking concerning this issue.
In our case-control study, the association
between acne vulgaris and smoking showed an
adjusted OR was 1.237 with a 95% CI (0.6592.319) which was not significant. Nevertheless,
the study showed a slightly increased risk among
smokers who were ≥ 20 years of age compared to
smokers who were <20 years of age with a
significant adjusted OR of 1.779 with a 95% CI
(1.006-3.148).
Results of this study support the idea of a true
association between smoking and acne after the
age of 20 years. This association has been
documented in previous studies as reported by
Capitanio et al (6). In contrast, our study does not
support that smoking has a direct association with
acne for all age groups as suggested by other
studies.
LIMITATIONS
Although the research has reached its aims,
there were some limitations. This research was
conducted on a small size population limited to
particular areas in Palestine. Therefore, to
generalize the results, the study should have
involved more participants from different areas.
Overall, we came out with a trustworthy result
with an interesting conclusion of an association
between smoking and acne for people more than
20 years of age. However, more research on
larger samples needs to be conducted to affirm
this association.
CONCLUSIONS
Smoking harms nearly every organ of the
body. It is responsible for many cancers, skin and
health problems. Smoking is certainly a topic to
counsel on whenever a smoker visits a
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dermatologist. With the raising evidence that
smoking has a role in the pathogenesis of acne,
dermatologists should make sure to discuss the
topic of smoking cessation when counselling their
patients for a healthier skin, free of acne.
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